Tags

Type your tag names separated by a space and hit enter

The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis.
Pept Res. 1989 Jan-Feb; 2(1):147-52.PR

Abstract

Fmoc-Cys(t-Bu)-OH, Fmoc-Cys(Acm)-OH, and Fmoc-Cys(Trt)-OH exhibit excellent synthesis characteristics when used in Fmoc solid phase peptide synthesis on the Applied Biosystems Model 431A peptide synthesizer. The actual 5% scavenger mixture will vary according to the particular amino acid residues present. As was previously mentioned, an anisole/ethanedithiol/ethylmethylsulfide mixture (3:1:1) works well as a general scavenger solution for TFA cleavage of Fmoc synthesized peptide resins. It also may be possible to use lower acid (TFA) concentrations. The syntheses and workups of the peptide Somatostatin utilizing these derivatives demonstrate the ease of using these cysteine derivatives with the Fmoc chemistry approach. The use of either the t-Bu or the Acm moiety produces a peptide containing protected thiol groups after cleavage with 95% TFA. The Fmoc-Cys(Trt)-OH derivative is efficiently deprotected using 95% TFA. This investigation should provide further insight into synthesis options and cleavage protocols when working with cysteine-containing peptides.

Authors+Show Affiliations

Applied Biosystems, Inc., Foster City, CA 94404.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2577698

Citation

McCurdy, S N.. "The Investigation of Fmoc-cysteine Derivatives in Solid Phase Peptide Synthesis." Peptide Research, vol. 2, no. 1, 1989, pp. 147-52.
McCurdy SN. The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis. Pept Res. 1989;2(1):147-52.
McCurdy, S. N. (1989). The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis. Peptide Research, 2(1), 147-52.
McCurdy SN. The Investigation of Fmoc-cysteine Derivatives in Solid Phase Peptide Synthesis. Pept Res. 1989 Jan-Feb;2(1):147-52. PubMed PMID: 2577698.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis. A1 - McCurdy,S N, PY - 1989/1/1/pubmed PY - 1989/1/1/medline PY - 1989/1/1/entrez SP - 147 EP - 52 JF - Peptide research JO - Pept Res VL - 2 IS - 1 N2 - Fmoc-Cys(t-Bu)-OH, Fmoc-Cys(Acm)-OH, and Fmoc-Cys(Trt)-OH exhibit excellent synthesis characteristics when used in Fmoc solid phase peptide synthesis on the Applied Biosystems Model 431A peptide synthesizer. The actual 5% scavenger mixture will vary according to the particular amino acid residues present. As was previously mentioned, an anisole/ethanedithiol/ethylmethylsulfide mixture (3:1:1) works well as a general scavenger solution for TFA cleavage of Fmoc synthesized peptide resins. It also may be possible to use lower acid (TFA) concentrations. The syntheses and workups of the peptide Somatostatin utilizing these derivatives demonstrate the ease of using these cysteine derivatives with the Fmoc chemistry approach. The use of either the t-Bu or the Acm moiety produces a peptide containing protected thiol groups after cleavage with 95% TFA. The Fmoc-Cys(Trt)-OH derivative is efficiently deprotected using 95% TFA. This investigation should provide further insight into synthesis options and cleavage protocols when working with cysteine-containing peptides. SN - 1040-5704 UR - https://www.unboundmedicine.com/medline/citation/2577698 DB - PRIME DP - Unbound Medicine ER -